On the one hand, defects in signaling pathways promoting cell growth and survival occur in cancer cells and high constitutive levels of MEK/ERK, PI3K/Akt, JAK/STAT or IKK/IκB/NF-κB pathways are frequently observed in human cancers [5,109]. Here, NFKB1 is linked to cancer.